2-Methoxyidazoxan hydrobromide

Br.COC1(COC2=CC=CC=C2O1)C3=NCCN3

InChIKey=HHOPTWIORLDHIT-UHFFFAOYSA-N

InChI=1S/C12H14N2O3.BrH/c1-15-12(11-13-6-7-14-11)8-16-9-4-2-3-5-10(9)17-12;/h2-5H,6-8H2,1H3,(H,13,14);1H

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Targets

Primary Target	Pharmacology	Potency
Alpha-2a adrenergic receptor 70 Target ID: CHEMBL1867 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7996470	Antagonist 2849	0.62 nM [Kd]
Alpha-2b adrenergic receptor 35 Target ID: CHEMBL1942 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7996470	Antagonist 2849	3.83 nM [Kd]
Alpha-2c adrenergic receptor 44 Target ID: CHEMBL1916 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7996470	Antagonist 2849	1.78 nM [Kd]

Substance Class	Chemical Created by `admin` on `Wed Apr 02 16:43:24 GMT 2025` Edited by `admin` on `Wed Apr 02 16:43:24 GMT 2025`
Record UNII	8TX9V9C9KG
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

1H-Imidazole, 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-, hydrobromide (1:1)

Preferred Name

English

2-Methoxyidazoxan hydrobromide

Common Name

English

1H-Imidazole, 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-, monohydrobromide

Systematic Name

English

Code System Code Type Description

CAS

131674-74-3

Created by admin on Wed Apr 02 16:43:24 GMT 2025 , Edited by admin on Wed Apr 02 16:43:24 GMT 2025

PRIMARY

FDA UNII

8TX9V9C9KG

Created by admin on Wed Apr 02 16:43:24 GMT 2025 , Edited by admin on Wed Apr 02 16:43:24 GMT 2025

PRIMARY

Related Record Type Details


					LZZ8E945TG

ENANTIOMER -> RACEMATE

Amount:


					E27LB7P0ET

PARENT -> SALT/SOLVATE

Amount: